ARIBIO CO., LTD.
7Patents
7Active
7Granted
43Portfolio score
Filing activity: Jul 11, 2012 → Aug 1, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10071128B2 | Method for preparing granules or pills containing extracts in high concentration | Human Necessities | 1 | Active |
| US9751840B2 | R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial | Chemistry; Metallurgy | 1 | Active |
| US9750743B2 | Composition comprising phosphodiesterase type 5 inhibitor for inhibiting apoptosis of nerve cells | Human Necessities | 0 | Active |
| US11191799B2 | Method for preparing granules or pills containing extracts in high concentration | Human Necessities | 0 | Active |
| US10265333B2 | Lipid nanomaterial containing lysophosphatidylcholine or derivative thereof and method for preparing same | Human Necessities | 0 | Active |
| US9452158B2 | R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1 acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial | Chemistry; Metallurgy | 0 | Active |
| US10064865B2 | Composition comprising phosphodiesterase type 5 inhibitor for inhibiting apoptosis of nerve cells | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.